tiprankstipranks
Trending News
More News >
APONTIS PHARMA AG (DE:APPH)
XETRA:APPH
Germany Market

APONTIS PHARMA AG (APPH) Financial Statements

Compare
6 Followers

APONTIS PHARMA AG Financial Overview

APONTIS PHARMA AG's market cap is currently €97.75M. The company's EPS TTM is €0.09; its P/E ratio is 127.07; APONTIS PHARMA AG is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue€ 48.47M€ 36.96M€ 55.73M€ 51.18M€ 39.24M
Gross Profit€ 27.70M€ 23.17M€ 34.99M€ 33.79M€ 25.03M
Operating Income€ 1.26M€ -15.10M€ 5.67M€ 1.67M-
EBITDA€ 3.56M€ -12.94M€ 5.67M€ 1.99M€ 1.04M
Net Income€ 753.57K€ -11.30M€ 2.69M--
Balance Sheet
Cash & Short-Term Investments€ 15.45M€ 26.82M€ 36.35M€ 29.84M€ 8.06M
Total Assets€ 44.37M€ 57.46M€ 59.85M€ 54.13M€ 29.69M
Total Debt€ 0.00€ 6.02M€ 0.00€ 0.00€ 0.00
Net Debt--€ -36.35M€ -29.84M€ -8.06M
Total Liabilities€ 13.36M€ 27.20M€ 18.29M€ 13.42M€ 26.23M
Stockholders' Equity€ 31.02M€ 30.26M€ 41.57M€ 40.71M€ 3.46M
Cash Flow
Free Cash Flow--€ 7.74M€ 1.77M€ 721.45K
Operating Cash Flow-€ -12.60M€ 11.02M€ 3.43M€ 1.45M
Investing Cash Flow-€ -2.90M---
Financing Cash Flow-€ 6.00M-€ 20.12M-
Currency in EUR

APONTIS PHARMA AG Earnings and Revenue History

APONTIS PHARMA AG Debt to Assets

APONTIS PHARMA AG Cash Flow

APONTIS PHARMA AG Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis